Bristol Myers Squibb (BMY) returns
Bristol Myers Squibb returns over 10 years
$1,000 invested in Bristol Myers Squibb ten years ago was worth $1,750 at the close on October 30, 2026, with dividends reinvested: an average return of 5.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +1.2% | — | $1,012 | -0.9% |
| 3 months | -2.7% | — | $973.23 | +2.1% |
| Year to date | +21.0% | — | $1,210 | +11.7% |
| 1 year | +43.0% | — | $1,430 | +12.4% |
| 3 years | +40.4% | +12.0% | $1,404 | +88.5% |
| 5 years | +31.6% | +5.6% | $1,316 | +76.0% |
| 10 years | +75.0% | +5.8% | $1,750 | +316.6% |
Bristol Myers Squibb return by calendar year
| Year | BMY | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +21.0% | +11.7% | +9.3% |
| 2025 | +0.1% | +17.7% | -17.6% |
| 2024 | +15.8% | +24.9% | -9.1% |
| 2023 | -26.2% | +26.2% | -52.3% |
| 2022 | +19.0% | -18.2% | +37.2% |
| 2021 | +2.9% | +28.7% | -25.9% |
| 2020 | +0.4% | +18.4% | -18.0% |
| 2019 | +27.9% | +31.2% | -3.4% |
| 2018 | -12.9% | -4.6% | -8.4% |
| 2017 | +7.7% | +21.7% | -14.0% |
| 2016 | -13.5% | +12.0% | -25.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: BMY financials · BMY valuation
No forecast, no recommendation. This page describes Bristol Myers Squibb from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.